top of page

ProstateGeneID

Hereditary Prostate Cancer Testing

​

​

ProstateGeneID is a non-invasive test performed by collecting a simple mouthwash sample. Genetic testing consists of screening for 18 genes to help identify whether a patient has a gene mutation that significantly increases cancer risk. Men with hereditary prostate cancer are born with DNA changes that increase their risk. Understanding risk can help with prevention and treatment. These changes can also be passed from parent to child. Women who inherit these changes may be at increased risk of a cancer diagnosis in the future. The 18 genes tested for in ProstateGeneID are linked to 8 cancer types.

​

Our Genes

And their associated risk to Prostate Cancer

ATM

Low To Moderate Risk

BRCA1

16-44% Risk

BRCA2

23-69% Risk

BRIP1

Emerging Risk

CHEK2

Low To Moderate Risk

ELAC2

Low To Moderate Risk

EPCAM

23-67% Risk

HOXB13

High Risk

MLH1

23-67% Risk

MRE11A

Emerging Risk

MSH2

23-67% Risk

MSH6

23-67% Risk

NBN

Low To Moderate Risk

PALB2

Low To Moderate Risk

PMS2

23-67% Risk

RAD51C

Emerging Risk

RAD51D

Low To Moderate Risk

TP53

Up to 54% Risk

FOR PROVIDERS

Request a ProstateGeneID demo or provider resources from GeneID.

Help your patients receive a more personalized cancer treatment experience.

FOR PATIENTS

Request a ProstateGeneID patient guide from GeneID.

Learn about your risks, options, and whether hereditary prostate cancer testing is right for you.

bottom of page